Intranasal insulin in Alzheimer disease (diabetes in situ?): a systematic review and meta-analysis
{{output}}
Alzheimer disease (AD) is a neurodegenerative disorder. Evidence suggests that AD shares pathophysiological similarities with type 2 diabetes. Intranasal insulin (INI) has emerged as a potential therapeutic approach for AD by directly targeting the brain and m... ...
